MIR93 (microRNA 93; HGNC:31645, NCBI Gene 407050) is the gene on chromosome 7q22.1 encoding miR-93 — the third member of the MCM7-hosted miR-106b~25~93 cluster, sharing the miR-17 seed family's proliferation program with a distinct hypoxia file: miR-93's repression of PTEN and the TGF-beta route in glioma and endothelial contexts.
Glioma and breast contexts; the paralog-cluster program
Gene Structure & Expression
Structure: The cluster's third hairpin, miR-106b and miR-25 flanking — MCM7's intron-13 hosting tying the cluster to replication licensing.
Expression: Cycling cells with the cluster; hypoxia and endothelial contexts the specific file.
Context depth: The glioma file centers on PTEN repression in PTEN-wildtype tumors — a route parallel to PTEN's own loss; the breast hypoxia program ties miR-93 to HIF-adjacent adaptation. The cluster's shared host means MCM7 co-amplification drags all three members along.
Assay note: The glioma file typically reports the cluster or the family jointly.
Assay note: The glioma and breast panels typically report the family jointly; the MCM7 host staining the pathology proxy.
Assay note: The glioma and breast panels report the family jointly; MCM7 immunostaining serves as the pathology proxy for the hosting architecture.
Molecular Function & Pathways
Shared seed program: p21/CDKN1A and E2F-family repression (the miR-17 family program — miR-17~92's page for the wiring), p21.
Specific targets: PTEN and LATS2 (the Hippo route) — miR-93's own contributions; glioma's PTEN-repression context and the breast-cancer hypoxia program.
Clinical & Therapeutic Significance
Oncology: Glioma (the PTEN-adjacent file), breast (the hypoxia program), and the family-wide attribution problem; the 7q22 amplification's contribution.
Vascular: Endothelial miR-93 in angiogenesis contexts — the miR-126-adjacent program.